Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen
*Company:
Novo Nordisk LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 02 October 2025
File name
Wegovy PIL_IE_v2_Sep2025_cl.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 02 October 2025
File name
Wegovy SmPC_IE_v2_Sep2025_cl.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 February 2025
File name
Wegovy PIL_IE_v1_Oct2024_cl.pdf
Reasons for updating
- New PIL for new product
Updated on 05 February 2025
File name
Wegovy SmPC_IE_v1_Oct2024_cl.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Novo Nordisk Limited
Address:
1st Floor, Block A, The Crescent Building, Northwood Business Park, Santry, Dublin 9, IrelandMedical Information E-mail:
infoireland@novonordisk.comTelephone:
+353 1 8629700 ,Fax:
+353 1 8629725Website:
https://www.novonordisk.ie